CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
allogeneic hematopoietic stem cell transplant (HCT), versus Conventional Care in patients with Active, Relapsed or Refractory Acute Myeloid...
Phase 3
Saint Louis, Missouri, United States and 23 other locations
Cancer is a condition where cells in a specific part of the body grow and reproduce uncontrollably. Acute myeloid leukemia...
Phase 2, Phase 3
St Louis, Missouri, United States and 34 other locations
of measurable residual disease (MRD) level in patients with acute myeloid leukemia (AML) who have completed induc...
Phase 2
St Louis, Missouri, United States
\[GO\]) improves survival of children/adolescents/young adults with acute myeloid leukemia (AML) in 1st relapse w...
Phase 3
St Louis, Missouri, United States and 89 other locations
will further contribute to this effort through the collection of leukemia cells pre- and post-in vivo IFN-γ therapy. As in the previously co...
Phase 2
St Louis, Missouri, United States and 2 other locations
and Venetoclax in participants with relapsed or refractory acute myeloid leukemia (AML) or myelodysplastic syndro...
Phase 1
St Louis, Missouri, United States and 15 other locations
). Both parts will be conducted in participants with previously untreated CD123+ AML who are ineligible for intensive chemotherapy....
Phase 2
St Louis, Missouri, United States and 31 other locations
VEN+AZA alone for the treatment of participants with newly diagnosed Acute Myeloid Leukemia (AML) with a mutation...
Phase 3
St Louis, Missouri, United States and 265 other locations
combination of ATRN-119 and decitabine in patients with TP53-mutated acute myeloid leukemia (AML) or higher-risk ...
Phase 1
St Louis, Missouri, United States
with cytarabine in patients with relapsed/refractory (r/r) acute myeloid leukemia (AML) or r/r higher-risk myelod...
Phase 1
St Louis, Missouri, United States and 11 other locations
Clinical trials
Research sites
Resources
Legal